Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis.


Journal

European journal of cancer (Oxford, England : 1990)
ISSN: 1879-0852
Titre abrégé: Eur J Cancer
Pays: England
ID NLM: 9005373

Informations de publication

Date de publication:
07 2023
Historique:
received: 26 01 2023
revised: 26 03 2023
accepted: 28 03 2023
medline: 12 6 2023
pubmed: 25 4 2023
entrez: 25 4 2023
Statut: ppublish

Résumé

Dedifferentiated melanoma (DedM) poses significant diagnostic challenges. We aimed to investigate the clinical, histopathological and molecular features of DedM. Methylation signature (MS) and copy number profiling (CNP) were carried out in a subgroup of cases. A retrospective series of 78 DedM tissue samples from 61 patients retrieved from EORTC (European Organisation for Research and Treatment of Cancer) Melanoma Group centres were centrally reviewed. Clinical and histopathological features were retrieved. In a subgroup of patients, genotyping through Infinium Methylation microarray and CNP analysis was carried out. Most patients (60/61) had a metastatic DedM showing most frequently an unclassified pleomorphic, spindle cell, or small round cell morphology akin to undifferentiated soft tissue sarcoma, rarely associated with heterologous elements. Overall, among 20 successfully analysed tissue samples from 16 patients, we found retained melanoma-like MS in only 7 tissue samples while a non-melanoma-like MS was observed in 13 tissue samples. In two patients from whom multiple specimens were analysed, some of the samples had a preserved cutaneous melanoma MS while other specimens exhibited an epigenetic shift towards a mesenchymal/sarcoma-like profile, matching the histological features. In these two patients, CNP was largely identical across all analysed specimens, in line with their common clonal origin, despite significant modification of their epigenome. Our study further highlights that DedM represents a real diagnostic challenge. While MS and genomic CNP may help pathologists to diagnose DedM, we provide proof-of-concept that dedifferentiation in melanoma is frequently associated with epigenetic modifications.

Identifiants

pubmed: 37098294
pii: S0959-8049(23)00167-3
doi: 10.1016/j.ejca.2023.03.032
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-14

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Juergen Hench (J)

Institute of Medical Genetics and Pathology, Division of Neuropathology, University Hospital Basel, Basel, Switzerland.

Daniela Mihic-Probst (D)

Institute of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Abbas Agaimy (A)

Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital, Erlangen, Germany.

Stephan Frank (S)

Institute of Medical Genetics and Pathology, Division of Neuropathology, University Hospital Basel, Basel, Switzerland.

Peter Meyer (P)

Institute of Medical Genetics and Pathology, Division of Neuropathology, University Hospital Basel, Basel, Switzerland.

Claus Hultschig (C)

Institute of Medical Genetics and Pathology, Division of Neuropathology, University Hospital Basel, Basel, Switzerland.

Sara Simi (S)

Section of Pathology, Department of Health Sciences, University of Florence, Florence, Italy.

Lucia Alos (L)

Department of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain.

Thiagarajah Balamurugan (T)

Unit of Pathology, Royal Surrey County Hospital, Guildford, UK.

Willeke Blokx (W)

Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Francesca Bosisio (F)

Department of Imaging & Pathology, Laboratory of Translational Cell & Tissue Research and Department of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

Rocco Cappellesso (R)

Pathological Anatomy Unit, Padua University Hospital, 35121 Padua, Italy.

Klaus Griewank (K)

Department of Dermatology, University Hospital of Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.

Eva Hadaschik (E)

Department of Dermatology, University Hospital of Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.

Leon C van Kempen (LC)

Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Pathology, University Hospital Antwerp, Antwerp, Belgium.

Werner Kempf (W)

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.

Maria Lentini (M)

Department of Human Pathology, University of Messina, Messina, Italy.

Luca Mazzucchelli (L)

Laboratory of Molecular Pathology, Institute of Pathology, Ente Ospedaliero Cantonale, Locarno, Switzerland.

Gaetana Rinaldi (G)

Sezione di Oncologia, Dipartimento di Discipline Chirurgiche, Oncologiche e Stomatologiche (Di.Chir.On.S.), Università degli Studi di Palermo, Palermo, Italy.

Piotr Rutkowski (P)

Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland.

Dirk Schadendorf (D)

Department of Dermatology, University Hospital of Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.

Bastian Schilling (B)

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.

Anna Szumera-Cieckiewicz (A)

Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland.

Joost van den Oord (J)

Department of Imaging & Pathology, Laboratory of Translational Cell & Tissue Research and Department of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

Mario Mandalà (M)

University of Perugia, Unit of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy. Electronic address: mario.mandala@unipg.it.

Daniela Massi (D)

Section of Pathology, Department of Health Sciences, University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH